Pharmacokinetics of a new orally disintegrating tablet formulation of aripiprazole 15 mg administered without water in healthy middle-aged Korean subjects

Y Kim, JY Jeon, YC Chung, MG Kim - Clinical Therapeutics, 2015 - Elsevier
Purpose The main objective of this study was to compare the pharmacokinetic properties
and relative bioavailability of two 15-mg aripiprazole formulations (an orally disintegrating …
被引用次数：8 相关文章 Web of Science: 6

Pharmacokinetics of a New Orally Disintegrating Tablet Formulation of Aripiprazole 15 mg Administered Without Water in Healthy Middle-aged Korean Subjects

Y Kim, JY Jeon, YC Chung, MG Kim - Clinical Therapeutics, 2015 - infona.pl
The main objective of this study was to compare the pharmacokinetic properties and relative
bioavailability of two 15-mg aripiprazole formulations (an orally disintegrating tablet [ODT] as …

Pharmacokinetics of a New Orally Disintegrating Tablet Formulation of Aripiprazole 15 mg Administered Without Water in Healthy Middle-aged Korean Subjects.

Y Kim, JY Jeon, YC Chung, MG Kim - Clinical Therapeutics, 2015 - europepmc.org
Purpose The main objective of this study was to compare the pharmacokinetic properties
and relative bioavailability of two 15-mg aripiprazole formulations (an orally disintegrating …

Pharmacokinetics of a New Orally Disintegrating Tablet Formulation of Aripiprazole 15 mg Administered Without Water in Healthy Middle-aged Korean Subjects

Y Kim, JY Jeon, YC Chung… - Clinical Therapeutics, 2015 - clinicaltherapeutics.com
Purpose The main objective of this study was to compare the pharmacokinetic properties
and relative bioavailability of two 15-mg aripiprazole formulations (an orally disintegrating …

Pharmacokinetics of a New Orally Disintegrating Tablet Formulation of Aripiprazole 15 mg Administered Without Water in Healthy Middle-aged Korean Subjects

Y Kim, JY Jeon, YC Chung, MG Kim - 2015 - pubmed.ncbi.nlm.nih.gov
Purpose The main objective of this study was to compare the pharmacokinetic properties
and relative bioavailability of two 15-mg aripiprazole formulations (an orally disintegrating …

[引用][C] Pharmacokinetics of a New Orally Disintegrating Tablet Formulation of Aripiprazole 15 mg Administered Without Water in Healthy Middle-aged Korean Subjects

Y Kim, JY Jeon, YC Chung, MG Kim - Clinical Therapeutics, 2015 - Elsevier Limited